{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:33:10Z","timestamp":1781789590244,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalradiologyonline.net","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.crad.2024.01.029","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T07:43:17Z","timestamp":1707378197000},"page":"e675-e681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CT-derived radiomics predict the growth rate of renal tumours in von Hippel\u2013Lindau syndrome"],"prefix":"10.1016","volume":"79","author":[{"given":"S.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dehghani Firouzabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Homayounieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.B.","family":"Turkbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.M.","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Malayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.crad.2024.01.029_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel\u2013Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"6 Pt 1","key":"10.1016\/j.crad.2024.01.029_bib2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","article-title":"The genetic basis of cancer of the kidney","volume":"170","author":"Linehan","year":"2003","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.crad.2024.01.029_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.sult.2016.10.002","article-title":"Hereditary renal tumour syndromes: update on diagnosis and management","volume":"38","author":"Gaur","year":"2017","journal-title":"Semin Ultrasound CT MR"},{"issue":"173","key":"10.1016\/j.crad.2024.01.029_bib4","first-page":"205","article-title":"Treatment strategies for hereditary kidney cancer: current recommendations and updates","volume":"34","author":"Singh","year":"2022","journal-title":"Discov Med"},{"issue":"6","key":"10.1016\/j.crad.2024.01.029_bib5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1148\/rg.2021210037","article-title":"Radiomics in oncology: a practical guide","volume":"41","author":"Shur","year":"2021","journal-title":"RadioGraphics"},{"issue":"10","key":"10.1016\/j.crad.2024.01.029_bib6","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1007\/s00261-022-03610-5","article-title":"An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel\u2013Lindau syndrome","volume":"47","author":"Anari","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10.1016\/j.crad.2024.01.029_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.2020191016","article-title":"Clear cell renal cell carcinoma growth correlates with baseline diffusion-weighted MRI in Von Hippel\u2013Lindau disease","volume":"295","author":"Farhadi","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2024.01.029_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinimag.2022.11.007","article-title":"CT radiomics for differentiating oncocytoma from renal cell carcinomas: systematic review and meta-analysis","volume":"94","author":"Dehghani Firouzabadi","year":"2023","journal-title":"Clin Imaging"},{"issue":"1","key":"10.1016\/j.crad.2024.01.029_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40644-021-00412-8","article-title":"CT-based multi-phase radiomic models for differentiating clear cell renal cell carcinoma","volume":"21","author":"Chen","year":"2021","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.crad.2024.01.029_bib10","article-title":"Radiomics models based on enhanced computed tomography to distinguish clear cell from non-clear cell renal cell carcinomas","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.crad.2024.01.029_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13244-021-01107-1","article-title":"Machine learning-based CT radiomics approach for predicting WHO\/ISUP nuclear grade of clear cell renal cell carcinoma: an exploratory and comparative study","volume":"12","author":"Xv","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1016\/j.crad.2024.01.029_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.570396","article-title":"Computed tomography radiomics for predicting pathological grade of renal cell carcinoma","volume":"10","author":"Yi","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.crad.2024.01.029_bib13","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","article-title":"Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management","volume":"36","author":"Maher","year":"2018","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.crad.2024.01.029_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ncpuro0179","article-title":"Management of von Hippel\u2013Lindau-associated kidney cancer","volume":"2","author":"Grubb","year":"2005","journal-title":"Nat Clin Pract Urol"},{"issue":"8","key":"10.1016\/j.crad.2024.01.029_bib15","article-title":"von Hippel\u2013Lindau disease: updated guideline for diagnosis and surveillance","volume":"65","author":"Louise","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.crad.2024.01.029_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13023-019-1206-2","article-title":"Growth characteristics and therapeutic decision markers in von Hippel\u2013Lindau disease patients with renal cell carcinoma","volume":"14","author":"Schuhmacher","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.crad.2024.01.029_bib17","series-title":"Encyclopedia of cancer","first-page":"1576","article-title":"Gompertzian growth curve","year":"2011"},{"issue":"11","key":"10.1016\/j.crad.2024.01.029_bib18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.19.02263","article-title":"Growth rates of genetically defined renal tumours: implications for active surveillance and intervention","volume":"38","author":"Ball","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.crad.2024.01.029_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10689-011-9503-5","article-title":"Active surveillance of renal masses in von Hippel\u2013Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months","volume":"11","author":"Zhang","year":"2012","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.crad.2024.01.029_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000333348","article-title":"Growth kinetics in von Hippel\u2013Lindau-associated renal cell carcinoma","volume":"88","author":"Jilg","year":"2012","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.crad.2024.01.029_bib21","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.21037\/tau-20-1271","article-title":"Natural history and growth kinetics of clear cell renal cell carcinoma in sporadic and von Hippel\u2013Lindau disease","volume":"10","author":"Li","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"8","key":"10.1016\/j.crad.2024.01.029_bib22","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00345-021-03602-y","article-title":"Radiomics to better characterize small renal masses","volume":"39","author":"Kuusk","year":"2021","journal-title":"World J Urol"},{"issue":"8","key":"10.1016\/j.crad.2024.01.029_bib23","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s00345-020-03578-1","article-title":"Natural history of untreated kidney cancer","volume":"39","author":"McAlpine","year":"2021","journal-title":"World J Urol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T20:32:06Z","timestamp":1717187526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926024000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0009926024000801"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2024.01.029","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CT-derived radiomics predict the growth rate of renal tumours in von Hippel\u2013Lindau syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2024.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}